Stocks · Health care · Pharmaceutical Preparations

Tango Therapeutics, Inc.

TNGX Clue Score51
United States Fiscal year ends December CIK 0001819133 Results filed 11 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Adam Crystal
3 Feb 2026
President, R&D
Sell
201
$12.90
$2.59K
Adam Crystal
3 Feb 2026
President, R&D
Sell
18,251
$12.26
$223.71K
Barbara Weber
3 Feb 2026
Director, Executive Chair
Sell
333
$12.90
$4.29K
Barbara Weber
3 Feb 2026
Director, Executive Chair
Sell
30,186
$12.26
$370.00K
Daniella Beckman
3 Feb 2026
Chief Financial Officer
Sell
113
$12.90
$1.46K
Daniella Beckman
3 Feb 2026
Chief Financial Officer
Sell
10,204
$12.26
$125.07K

What was left out

Form 4 filings counted 26
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 16
Sales at will 6
Transactions with no price 0
Shares from compensation/vesting 804,382
History held since 10 Sep 2020